Target intelligence / Profile preview

MAN2A2 antisense RNA 1 (MAN2A2-AS1)

Target
MAN2A2-AS1
Molecular classification
Long non-coding RNA (lncRNA), Antisense RNA
01

Overview

MAN2A2 antisense RNA 1 (MAN2A2-AS1) is a long non-coding RNA transcribed in the antisense orientation relative to the MAN2A2 gene: it does not encode a protein and is not a conventional pharmacological target. Like other antisense lncRNAs, MAN2A2-AS1 is presumed to play a regulatory role at its genomic locus, potentially influencing the expression or processing of the sense MAN2A2 transcript via cis-acting mechanisms, chromatin modification, or RNA-RNA interactions[4]. Antisense RNAs and lncRNAs can contribute to gene regulatory networks involved in normal physiology and disease, but MAN2A2-AS1 itself has not yet been directly linked to a specific pathology or drug interaction. If you need information about MAN2A2 (the protein-coding gene), see the entries for "Mannosidase alpha class 2A member 2"[1].

02

Mechanism of action

(general mechanisms for antisense RNAs/lncRNAs, as no MAN2A2-AS1–specific data are available) - Inhibition of sense transcript expression - Modulation of chromatin structure at the MAN2A2 locus - Recruitment of RNA-binding proteins or chromatin modifiers[4]

03

Biological functions

Regulation of gene expression (cis and/or trans effects on sense transcript)Epigenetic regulation (by analogy with other well-characterized antisense RNAs)[4]
04

Disease associations

Other
05

Safety considerations

No direct evidence for drug safety concerns, as MAN2A2-AS1 is not a drug target. General concerns for targeting lncRNAs/antisense RNAs (e.g., off-target effects, gene regulation complexity) may apply if future therapeutics are considered[4].

Beyond the preview

Go deeper on MAN2A2 antisense RNA 1 (MAN2A2-AS1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on MAN2A2 antisense RNA 1 (MAN2A2-AS1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call